Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aflibercept
15%
Age-related Macular Degeneration
51%
Anatomical Outcomes
30%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
16%
Best-corrected Visual Acuity
26%
Bevacizumab
34%
Cataract Surgery
17%
Central Macular Thickness
15%
Central Retinal Artery
20%
Central Serous Chorioretinopathy
17%
Ciliary Artery
22%
Color Doppler Imaging
16%
Diabetic Macular Edema
26%
Dorzolamide
20%
Endophthalmitis
24%
Epiretinal Membrane
24%
Exudative Age-related Macular Degeneration
17%
Glaucoma
37%
Intraocular Pressure
59%
Intravitreal Bevacizumab
27%
Intravitreal Injection
37%
Intravitreal Ranibizumab
37%
Israel
16%
Medical Center
15%
Myopic Choroidal Neovascularization (mCNV)
59%
Neovascular Age-related Macular Degeneration (nAMD)
23%
Ocular Blood Flow
51%
Ocular Hemodynamics
21%
Optic Nerve
20%
Optic Nerve Head
20%
Optical Coherence Tomography Angiography (OCT-A)
17%
Pars Plana Vitrectomy
34%
Photodynamic Therapy
50%
Pigment Epithelium Detachment
18%
Postoperative Complications
15%
Primary Open-angle Glaucoma
52%
Prognostic Factors
20%
Proliferative Diabetic Retinopathy
20%
Retina
28%
Retinal Detachment Surgery
28%
Retinal Diseases
20%
Retinopathy of Prematurity
33%
Retrobulbar Blood Flow
22%
Rhegmatogenous Retinal Detachment
40%
Small-gauge Vitrectomy
21%
Submacular Hemorrhage
15%
Tissue Plasminogen Activator (t-PA)
15%
Visual Acuity
100%
Visual Function
21%
Visual Outcome
32%
Medicine and Dentistry
Age Related Macular Degeneration
45%
Agents Acting on the Eye
15%
Amaurosis Fugax
13%
Anatomical Concepts
20%
Best Corrected Visual Acuity
23%
Bevacizumab
33%
Bimatoprost
13%
Bleeding
22%
Blood Flow
44%
Blurred Vision
13%
Cataract Surgery
23%
Central Retinal Artery
14%
Central Serous Retinopathy
17%
Choroidal Neovascularization
57%
Ciliary Artery
15%
Color Doppler Flowmetry
15%
Diseases
18%
Dorzolamide
20%
Endophthalmitis
18%
Epiretinal Membrane
34%
Fluorocarbon
14%
Glaucoma
52%
Hemodynamic
17%
Inflammation
13%
Injection
61%
Intraocular Pressure
57%
Intravitreal Administration
16%
Macular Hole
18%
Ocular Blood Flow
34%
Open Angle Glaucoma
39%
Optic Nerve
33%
Optical Coherence Tomography
25%
Optical Coherence Tomography Angiography
16%
Pars Plana Vitrectomy
51%
Photochemotherapy
43%
Postoperative Complication
15%
Prognostic Factor
20%
Proliferative Diabetic Retinopathy
17%
Retina Disease
13%
Retinal Blood Vessel
14%
Retinal Break
15%
Retinal Detachment
81%
Retinopathy of Prematurity
20%
Suture
13%
Triamcinolone Acetonide
21%
Uveitis
20%
Vision
15%
Visual Acuity
93%
Vitrectomy
24%
Vitreous
20%
Nursing and Health Professions
Aflibercept
13%
Age Related Macular Degeneration
35%
Agents Acting on the Eye
11%
Angiography
7%
Bevacizumab
41%
Blood Flow
32%
Blurred Vision
13%
Brain Hemorrhage
8%
Central Corneal Thickness
6%
Central Serous Retinopathy
8%
Diode Laser
9%
Diseases
14%
Efficacy
8%
Endophthalmitis
8%
Epiretinal Membrane
15%
Etiology
11%
Eye Examination
8%
Fluorescence Angiography
6%
Glaucoma
27%
Heart Atrium Septum Defect
13%
Hemodynamic
10%
Imaging
20%
Injection
48%
Intracranial Pressure
7%
Intraocular Pressure
32%
Intravitreal Drug Administration
15%
Laser Coagulation
11%
Meta Analysis
13%
Open Angle Glaucoma
20%
Optical Coherence Tomography
14%
Optical Coherence Tomography Angiography
10%
Oximetry
8%
Pars Plana Vitrectomy
7%
Pathophysiology
9%
Photochemotherapy
30%
Prematurity
10%
Retina Detachment
34%
Retrolental Fibroplasia
26%
Septal Occluder
8%
Strabismus Surgery
6%
Student T Test
9%
Subretinal Neovascularization
38%
Systematic Review
13%
Transcranial Doppler
8%
Transitional Blindness
13%
Triamcinolone Acetonide
7%
Uveitis
14%
Vasculotropin
8%
Visual Acuity
48%
Wet Macular Degeneration
22%